[go: up one dir, main page]

JPS4940922B1 - - Google Patents

Info

Publication number
JPS4940922B1
JPS4940922B1 JP45125049A JP12504970A JPS4940922B1 JP S4940922 B1 JPS4940922 B1 JP S4940922B1 JP 45125049 A JP45125049 A JP 45125049A JP 12504970 A JP12504970 A JP 12504970A JP S4940922 B1 JPS4940922 B1 JP S4940922B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP45125049A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4940922B1 publication Critical patent/JPS4940922B1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP45125049A 1969-12-31 1970-12-30 Pending JPS4940922B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6945776A FR2073293B1 (en) 1969-12-31 1969-12-31

Publications (1)

Publication Number Publication Date
JPS4940922B1 true JPS4940922B1 (en) 1974-11-06

Family

ID=9045518

Family Applications (1)

Application Number Title Priority Date Filing Date
JP45125049A Pending JPS4940922B1 (en) 1969-12-31 1970-12-30

Country Status (11)

Country Link
JP (1) JPS4940922B1 (en)
AT (1) AT301749B (en)
BE (1) BE760727A (en)
CA (1) CA956573A (en)
CH (1) CH533988A (en)
DE (1) DE2064296C2 (en)
DK (1) DK128054B (en)
FR (1) FR2073293B1 (en)
GB (1) GB1326928A (en)
LU (1) LU62332A1 (en)
NL (1) NL7019097A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5330639U (en) * 1976-08-20 1978-03-16

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664494A5 (en) * 1979-10-11 1988-03-15 Liborio Dott Bonifacio PROCEDURE FOR PREPARING ANTIDOTES FOR THE PREVENTION AND TREATMENT OF CANCER, FROM GOATS' EXCMENT.
JPS5925332A (en) * 1982-08-04 1984-02-09 Mochida Pharmaceut Co Ltd Method for producing antitumor glycoprotein
FR2568125B1 (en) * 1984-07-25 1988-04-15 Kogo Michiko ANTI-TUMOR AGENT CONTAINING SUGAR PROTEIN
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5330639U (en) * 1976-08-20 1978-03-16

Also Published As

Publication number Publication date
AT301749B (en) 1972-09-11
LU62332A1 (en) 1971-05-27
GB1326928A (en) 1973-08-15
FR2073293B1 (en) 1973-01-12
DE2064296C2 (en) 1984-10-25
CA956573A (en) 1974-10-22
DK128054B (en) 1974-02-25
FR2073293A1 (en) 1971-10-01
CH533988A (en) 1973-02-28
BE760727A (en) 1971-05-27
DE2064296A1 (en) 1971-07-15
NL7019097A (en) 1971-07-02

Similar Documents

Publication Publication Date Title
AU465452B2 (en)
CS152369B2 (en)
FR2073293B1 (en)
AU442375B2 (en)
AU427401B2 (en)
AU470301B1 (en)
AU442357B2 (en)
AU442535B2 (en)
AU442538B2 (en)
AU442554B2 (en)
AU442463B2 (en)
AU442380B2 (en)
AU442322B2 (en)
AU470661B1 (en)
AU428129B2 (en)
AU442285B2 (en)
AU5397469A (en)
CS148423B1 (en)
AU5077469A (en)
AU4540468A (en)
AU5228269A (en)
AU4949169A (en)
BE738282A (en)
AU448562A (en)
AU4815038A (en)